Phase II Study of Nimotuzumab Plus PF as Induction Chemotherapy in Patients With Locally Advanced HNSCC.
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2012
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 05 Jun 2009 New trial record